Brief Company History

CardioGenics was founded in Toronto, Ontario in 1997 as a biotechnology company dedicated to the development of products for the In-Vitro-Diagnostics market to meet unfulfilled needs. At the heart of CardioGenics Platform is a core technology for improving testing sensitivity to POC products.

CardioGenics has harnessed its core technology to build a compact POC analyzer that employs the most sensitive detection technology, chemiluminescence.

CardioGenics Team

Stock Info

Information for stock quote is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be delayed.